Breaking News
Grand Theft World Podcast 257 | FOREIGN AFFAIRS with guest Ernest Hancock
Why I Talk About Agorism
Trump's WAR Against Thomas Massie and Rand Paul
NASA's "Alien Probe" & The Comet Cover Story -- with Clay Clark
Top Tech News
Graphene Dream Becomes a Reality as Miracle Material Enters Production for Better Chips, Batteries
Virtual Fencing May Allow Thousands More Cattle to Be Ranched on Land Rather Than in Barns
Prominent Personalities Sign Letter Seeking Ban On 'Development Of Superintelligence'
Why 'Mirror Life' Is Causing Some Genetic Scientists To Freak Out
Retina e-paper promises screens 'visually indistinguishable from reality'
Scientists baffled as interstellar visitor appears to reverse thrust before vanishing behind the sun
Future of Satellite of Direct to Cellphone
Amazon goes nuclear with new modular reactor plant
China Is Making 800-Mile EV Batteries. Here's Why America Can't Have Them
China Innovates: Transforming Sand into Paper
New blood, computer brains and frozen heads: How billionaires 'will live forever'
Over the past year, the gap between the super-rich and the rest of us has grown wider than ever before.
But the difference between ordinary people and billionaires might be more than just money. Some high net worth individuals have been looking into extending their lives far beyond the 70 or 80 years most of us might hope for.
Peter Thiel, for example, the billionaire co-founder of PayPal, has invested in a number medical research start-ups looking extending life expectancy though his Breakout Labs fund.
One of the companies longevity obsessive Thiel has bankrolled is Ambrosia.
Ambrosia is one of three outfits looking at experimental "vampire" blood transfusions that put the blood of young people into the lens of oldies.
According to commercial finance experts ABC Finance, the cost of the trials currently ranges from £6,000 to about £215,000.